Aisling Capital Management’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.2M | Hold |
615,352
|
|
||||
|
2025
Q1 | $39.1M | Sell |
615,352
-500,000
|
|
||||
|
2024
Q4 | $51.8M | Hold |
1,115,352
|
|
||||
|
2024
Q3 | $32.1M | Hold |
1,115,352
|
|
||||
|
2024
Q2 | $16.1M | Hold |
1,115,352
|
|
||||
|
2024
Q1 | $17.9M | Hold |
1,115,352
|
|
||||
|
2023
Q4 | $22.2M | Hold |
1,115,352
|
|
||||
|
2023
Q3 | $18.2M | Hold |
1,115,352
|
|
||||
|
2023
Q2 | $23.6M | Hold |
1,115,352
|
|
||||
|
2023
Q1 | $22.4M | Sell |
1,115,352
-217,133
|
|
||||
|
2022
Q4 | $34.8M | Hold |
1,332,485
|
|
||||
|
2022
Q3 | $13.6M | Hold |
1,332,485
|
|
||||
|
2022
Q2 | $5.58M | Hold |
1,332,485
|
|
||||
|
2022
Q1 | $6.65M | Hold |
1,332,485
|
|
||||
|
2021
Q4 | $8.95M | Hold |
1,332,485
|
|
||||
|
2021
Q3 | $7.3M | Hold |
1,332,485
|
|
||||
|
2021
Q2 | $8.71M | Hold |
1,332,485
|
|
||||
|
2021
Q1 | $11.1M | Hold |
1,332,485
|
|
||||
|
2020
Q4 | $9.33M | Hold |
1,332,485
|
|
||||
|
2020
Q3 | $8.31M | Buy |
1,332,485
+888,889
|
|
||||
|
2020
Q2 | $2.07M | Hold |
443,596
|
|
||||
|
2020
Q1 | $1.83M | Hold |
443,596
|
|
||||
|
2019
Q4 | $2.55M | Hold |
443,596
|
|
||||
|
2019
Q3 | $2.03M | Hold |
443,596
|
|
||||
|
2019
Q2 | $2.26M | Hold |
443,596
|
|
||||
|
2019
Q1 | $2.88M | Hold |
443,596
|
|
||||
|
2018
Q4 | $4.28M | Buy |
+443,596
|
|